Cat. No. 2504
Alternative Name: MN 1695
Chemical Name: 6-(2,5-Dichlorophenyl)-1,3,5-triazi
Biological ActivityPhosphodiesterase 4 (PDE4) inhibitor that displays gastroprotective properties. Prevents gastric mucosal injury induced by monochloramine and ischemia-reperfusion. Activates gap-junctional intercellular communication improving gastric mucosal barrier function. Inhibits superoxide production in human neutrophils and inhibits in vitro and in vivo angiogenesis.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Data Sheet
Kyoi et al (2004) Phosphodiesterase type IV inhibitors prevent ischemia-reperfusion-induced gastric injury in rats. J.Pharmacol.Sci. 95 321. PMID: 15272207.
Kyoi et al (2004) Irsogladine, an anti-ulcer drug, suppresses superoxide production by inhibiting phosphodiesterase type 4 in human neutrophils. Life Sci. 76 71. PMID: 15501481.
Nozaki et al (2004) Inhibition of breast cancer regrowth and pulmonary metastasis in nude mice by anti-gastric ulcer agent, irsogladine. Breast Cancer Res.Treat. 83 195. PMID: 14758089.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses Irsogladine maleate from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: Irsogladine maleate, supplier, PDE4, inhibitors, inhibits, antiulcer, agent, Phosphodiesterases, MN1695, Tocris Bioscience, Phosphodiesterase Inhibitor products
Find multiple products by catalog number
New Products in this Area
Potent PDE9 inhibitor; brain penetrantEggmanone
Potent and selective PDE4 inhibitor; suppresses hedgehog signalingAdaptaquin
HIF-prolyl hydroxylase-2 (PHD2) inhibitor; antioxidant
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.